01:21 PM EDT, 08/12/2024 (MT Newswires) -- Envoy Medical ( COCH ) shares were up nearly 14% in recent Monday trading after the company reported its Q2 results.

The company's Q2 loss of $0.27 per diluted share narrowed from a loss of $1.31 reported a year earlier.

One analyst polled by Capital IQ expected a loss of $0.26.

Revenue for the quarter ended June 30 was $68,000, up from $63,000 a year earlier.

Three analysts surveyed by Capital IQ expected $80,000.

As of June 30, Envoy Medical ( COCH ) had cash and cash equivalents of about $1.7 million.

Price: 2.70, Change: +0.33, Percent Change: +13.88